Clinical trial Recruiting at 1 site Observational Ages 3 to 18

Leptin Levels in Children With Adenoid/Adenotonsillar Hypertrophy

Official title: Comparison of Serum and Salivary Leptin Levels in Children With and Without Adenoid/Adenotonsillar Hypertrophy

Run by Harran University · NCT07887451 · Data updated 2026-11-12

This study tests whether leptin levels in blood and saliva differ between children with enlarged adenoids or adenoids plus tonsils and children without those problems.

More Adenotonsillar Hypertrophy trials

Quick facts

Study typeObservational
Ages3 Years to 18 Years
SexAll
Enrollment80 (estimated)
SponsorHarran University
Academic / other
Locations1 site (Sanliurfa, Şanlıurfa)
StatusRecruiting
StartedMarch 2, 2026
Main results expectedDecember 31, 2026
Study endsJanuary 31, 2027
Registry record updatedOctober 21, 2026
Trial IDNCT07887451 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal participants are children aged 3–18 with documented adenoid hypertrophy or adenoid plus tonsil hypertrophy and no other systemic diseases.

Probably not a fit

Children with obesity, growth disorders, or significant systemic illnesses may not show a leptin difference or may not benefit from this biomarker.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective observational study compares serum and salivary leptin levels in children aged 3–18 with adenoid or adenotonsillar hypertrophy to age- and sex-matched controls without hypertrophy. Leptin, an appetite-regulating hormone, is measured in fasting morning samples using ELISA, and relationships with height, weight, and BMI are analyzed. The goal is to see if saliva leptin reflects serum leptin and whether leptin levels relate to growth metrics in the two groups. Statistical tests will include t-tests or nonparametric equivalents and correlation analyses. Participants are recruited from the Harran University Faculty of Medicine Hospital, with 40 in each group.

Why it matters

Potential benefit: If proven, salivary leptin could serve as a non-invasive biomarker to understand growth and metabolism in children with nasal obstruction.

How similar studies have gone: Other studies have explored leptin in pediatric populations, but this exact saliva-serum comparison in adenoid-related disease is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Adenoid/Adenotonsillar Hypertrophy Group

Inclusion Criteria:

* Age 3 to 18 years
* Diagnosis of adenoid hypertrophy or adenoid and palatine tonsil hypertrophy at the Otorhinolaryngology outpatient clinic by clinical examination with or without endoscopic evaluation
* Stable general condition without known chronic systemic disease
* No medical contraindication to venous blood and saliva sampling
* Written informed consent obtained from a parent or legal guardian

Exclusion Criteria:

* Signs of acute upper or lower respiratory tract infection at the time of sampling or within the previous 2 weeks
* Chronic endocrine, metabolic, cardiac, renal, hepatic or hematologic systemic disease
* Obesity, growth retardation or a clinically diagnosed nutritional disorder
* Previous adenoidectomy or adenotonsillectomy
* Use of systemic corticosteroids, hormone preparations or immunomodulatory drugs within the last 3 months
* Insufficient cooperation during clinical evaluation or sampling, or inability to obtain an adequate blood and/or saliva sample
* Lack of written informed consent from a parent or legal guardian

Control Group

Inclusion Criteria:

* Age 3 to 18 years
* No adenoid or adenotonsillar hypertrophy on clinical and endoscopic evaluation
* No history of nasal obstruction, chronic snoring or sleep-disordered breathing
* Similar age and sex distribution to the patient group
* No known chronic systemic disease and no medical contraindication to venous blood and saliva sampling
* Written informed consent obtained from a parent or legal guardian

Exclusion Criteria:

\* Same exclusion criteria as the patient group

Where it's running

  • Harran University Faculty of Medicine Hospital, Department of Otorhinolaryngology
    Sanliurfa, Şanlıurfa, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.